Pfizer Releases New Clinical Trial Results for COVID-19 Vaccine

November 27, 2020

Pfizer Releases New Clinical Trial Results for COVID-19 Vaccine

Pfizer has announced that clinical trials demonstrate that their COVID-19 vaccine candidate is 95% effective and causes no serious adverse side effects. Pfizer produced the vaccine along with BioNTech—the company plans to apply for FDA emergency authorization “within days.” Yourway has extensive experience shipping and distributing high-value drug products and the requisite quality and regulatory compliance needed to ship and store all types of therapeutics around the world.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Global Clinical Supplies Group Asia Pacific Conference

March 10-12, 2026
Conrad Seoul Hotel, South Korea

Schedule a Meeting

Clinical Trial Supply New England

April 14-15, 2026
Boston, MA

Schedule a Meeting

Media

Articles

Why Integration Matters in Clinical Supply Chains

Open chat

Hello! How can I help you?